BioWorld MedTech

May 31, 2012

The MDD Interview: Hoping that benefits, needs can carry the day for new products

Robert Ward is chairman of Emergence Venture Partners, president of ExThera Medical (both Berkeley, California), and founder and former president of the Polymer Technology Group (PTG), now DSM Biomedical. Read More

ViewRay gains clearance for MRI guided radiation therapy system

Washington roundup: House passes FDA user fee legislation with voice vote

Agreements/contracts: Spacelabs provides solutions to Texas hospital department

Financings roundup: Kona Medical raises $30M in 'C' round of financing

Patents roundup: Miracor strengthens patent protection for PICSO in U.S.

International report: Symmetry to drive expansion in Australia and New Zealand

Product Briefs

HIT roundup: HL7 recruiting physicians to bolster EHR standards

People in the News

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for April 15, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 15, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

Antibodies binding to spike proteins on the surface of SARS-CoV-2 virus

Australian researchers discover new compound to treat long COVID

BioWorld

Researchers have developed a new compound that can prevent long COVID symptoms in mice that could lead to a future drug for the debilitating condition in humans....

Blood glucose chart and monitor, stethoscope, injector pen

Hightide’s HTD-1801 meets phase III endpoints in type 2 diabetes

BioWorld

Hightide Therapeutics Inc.’s berberine ursodeoxycholate (HTD-1801) met primary and secondary endpoints in the Symphony 1 and Symphony 2 phase III trials in type 2...